Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Other Accumulated Expenses (2020 - 2022)

SOPHiA GENETICS's Other Accumulated Expenses history spans 3 years, with the latest figure at $12000.0 for Q1 2022.

  • On a quarterly basis, Other Accumulated Expenses changed N/A to $12000.0 in Q1 2022 year-over-year; TTM through Mar 2022 was $12000.0, a N/A change, with the full-year FY2021 number at $12000.0, down 75.0% from a year prior.
  • Other Accumulated Expenses hit $12000.0 in Q1 2022 for SOPHiA GENETICS, roughly flat from $12000.0 in the prior quarter.
  • Over the last five years, Other Accumulated Expenses for SOPH hit a ceiling of $2.9 million in Q2 2021 and a floor of $12000.0 in Q4 2021.
  • Historically, Other Accumulated Expenses has averaged $631600.0 across 3 years, with a median of $48000.0 in 2020.
  • The widest YoY moves for Other Accumulated Expenses: up 75.0% in 2021, down 75.0% in 2021.
  • Tracing SOPH's Other Accumulated Expenses over 3 years: stood at $48000.0 in 2020, then crashed by 75.0% to $12000.0 in 2021, then changed by 0.0% to $12000.0 in 2022.
  • Business Quant data shows Other Accumulated Expenses for SOPH at $12000.0 in Q1 2022, $12000.0 in Q4 2021, and $227000.0 in Q3 2021.